Journal Navigation
Glucolipid Metabolic Disease (GMD)

Glucolipid Metabolic Disease (GMD)

Published in Partnership with Guangdong Pharmaceutical University, China

Open Access Funding Provided by Guangdong Pharmaceutical University, China

Editor-in-Chief: Jiao Guo (Guangdong Pharmaceutical University, China)
Published: Continuous Volume |Established: 2023
ISSN: 2831-4697|EISSN: 2831-4689|DOI: 10.4018/GMD
Journal Metrics
Submission to Acceptance: Metrics Pending
Acceptance to Publication: Metrics Pending
Acceptance Rate: Metrics Pending
Latest Published Articles
Articles Coming Soon.
Description, Mission, Scope & Coverage
Description:
Glucolipid Metabolic Disease (GMD) is an innovative journal that presents peer-reviewed clinical and scientific research on the identification, prevention, control, and treatment of glucolipid metabolic diseases (GLMD). Due to lifestyle changes in recent years, this chronic disorder has resulted... Show More
Mission & Scope:
Glucolipid Metabolic Disease (GMD) seeks to share the latest quality research encompassing all aspects of glucolipid metabolic diseases. As an international journal with global contributions and reach, it aims to blend Eastern and Western perspectives and practices to determine the best prevention and control methods for these types of disorders. In order to combat the rise of GLMD, alternative... Show More
Coverage:
  • Alternative Medicine
  • Arteriosclerotic Cardiovascular and Cerebrovascular Diseases
  • Chronic Disorders
  • Complementary Medicine
  • Diabetes
  • Dyslipidemia
  • Eastern Medicine
  • Epidemiology
  • Glucolipid Metabolic Diseases
  • Glucolipid Metabolism
  • Glycolipid Metabolic Diseases
  • Hyperglycemia
  • Inflammation
  • Insulin Resistance
  • Integrative Medicine
  • Intestinal Flora Disorders
  • Metabolic Disorders
  • Neuroendocrine Disorders
  • Neurological Diseases
  • Non-Alcoholic Fatty Liver Disease
  • Obesity
  • Oxidative Stress
  • Pathogenesis
  • Public Health
  • Traditional Medicine
  • Western Medicine
Editorial Board

Editorial Board

Editorial Board is currently being developed.
Editorial Policy
IGI Global holds its journals to the highest ethical practices. View Full Editorial Policy
IGI Global Open Access
As an academic publisher at the forefront of advancement for over 30 years, IGI Global OA provides quality, expediate OA publishing with a top-of-the-line production system backed by the international Committee on Publication Ethics (COPE). With a streamlined publishing process, flexible funding options, and more, researchers can freely and immediately share their peer-reviewed research with the world.
  • Rigorous and Expediate Publishing Process
  • Research Is Fully Free and Accessible to All (Creative Commons BY License)
  • Increased Discoverability of Published Content (89% Higher Download Rate)
  • Acceleration of Citation Impact & Increased Indexing Potential
  • Greater Visibility & Wider Professional Recognition
  • Opportunities for Networking & Collaboration
  • Supports Overall Career Advancement
  • Affordable Article/Chapter Processing Charges (APCs/CPCs) (Starting at US$ 500)
  • And More.
Article Processing Charges
Article Processing Charge (APC):

Payment of the APC fee (directly to the publisher) by the author or a funding body is not required until AFTER the manuscript has gone through the full double-blind peer review process and the Editor(s)-in-Chief at his/her/their full discretion has/have decided to accept the manuscript based on the results of the double-blind peer review process. 
Please note that IGI Global cannot schedule the article for publication or publish the article until payment has been received. It is also important to note that in scholarly publishing, utilizing an open access journal's resources and time with no intent to pay the open access Article Processing Charge (APC) if the article manuscript is accepted following the peer review process is considered to be unethical and exploitative.

What Does IGI Global's Open Access APC Cover?

In the traditional subscription-based model, the cost to the publisher to produce each article is covered by the revenue generated by journal subscriptions. Under OA, all the articles are published under a Creative Commons (CC BY) license; therefore, the authors or funding body will pay a one-time article processing charge (APC) to offset the costs of all of the activities associated with the publication of the article manuscript, including:

  • Digital tools used to support the manuscript management and review process
  • Typesetting, formatting and layout
  • Online hosting
  • Submission of the journal's content to numerous abstracts, directories, and indexes
  • Third-party software (e.g. plagiarism checks)
  • Editorial support which includes manuscript tracking, communications, submission guideline checks, and communications with authors and reviewers
  • All promotional support and activities which include metadata distribution, press releases, promotional communications, web content, ads, fliers, brochures, postcards, etc. for the journal and its published contents
  • The fact that all published articles will be freely accessible and able to be posted and disseminated widely by
    the authors
  • Professional line-by-line English language copy editing and proofreading*

*This service is only performed on article manuscripts with fully paid (not discounted or waived) APC fees.

APC Subsidizing and Funding

To assist researchers in covering the costs of the APC in OA publishing, there are various sources of OA funding. Additionally, unlike many other publishers, IGI Global offers flexible subsidies, 100% Open Access APC funding, discounts, and more. Learn More

Open Access Funding Resources
IGI Global recognizes that many researchers may not know where to begin when searching for OA funding opportunities. IGI Global recently launched an Open Access Funding Resources page for researchers to browse. This page provides a comprehensive list of OA funding sources available for researchers to secure funds for their various OA publications.
Submit to This Journal
This journal is currently actively seeking new submissions. Interested authors should ensure that their article manuscript adheres to the journal's submission guidelines and utilize the journal article template, which include originality of the manuscript, professional English language copy editing, APA formatting tips, and more. To submit an article for consideration, please begin the submission process below.
Contact
Dr. Jiao Guo
Guangdong Pharmaceutical University, China
Editor-in-Chief
Glucolipid Metabolic Disease (GMD)
&
Alexis Miller
IGI Global
Journal Development Coordinator
Glucolipid Metabolic Disease (GMD)

Email: gmd-editorial-team@igi-global.com
Archiving
All of IGI Global's content is archived via the CLOCKSS and LOCKSS initiative. Additionally, all IGI Global published content is available in IGI Global's InfoSci® platform.